VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NGVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NGVTIngevity Corporation
$77.12$2.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NGVT logoIngevity Corporation(NGVT)Earnings, Financials & Key Ratios

NGVT•NYSE
$77.12
Price updated Jun 27, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustryCarbon and activated carbon materials
AboutIngevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.Show more
  • Revenue$1.17B-17.0%
  • EBITDA$368M
  • Net Income-$167M+61.2%
  • EPS (Diluted)-4.61+61.1%
  • Gross Margin39.53%+22.3%
  • EBITDA Margin31.54%+20.5%
  • Operating Margin22.43%+21.4%
  • Net Margin-14.31%+53.2%
  • ROE-148.6%-42.7%

NGVT Price & Volume

Ingevity Corporation (NGVT) stock price & volume — 10-year historical chart

Loading chart...

Structural Revenue Contraction Challenges Equity Base Stability

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Mixed
Primary Risk:Rapid equity base erosion

Key Thesis Takeaways

  • Ingevity faces significant structural headwinds as its core automotive and industrial chemical segments struggle with secular demand declines, evidenced by a 9.2% year-over-year revenue contraction in 2026Q1.
  • The company's financial foundation appears increasingly fragile, characterized by a rapid erosion of equity to $38.9 million and a debt-to-equity ratio that has surged to 30.96.
  • Investors should remain cautious as the firm continues to prioritize $52.3 million in share repurchases despite persistent net income volatility and the near-total impairment of $523.2 million in historical goodwill.

Verdict Logic

the company's precarious financial position is highlighted by a debt-to-equity ratio of 30.96 and a consistent pattern of negative net income, which suggests significant long-term solvency risks.

NGVT Growth Metrics

Ingevity Corporation (NGVT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.89%
5 Years-0.81%
3 Years-11.21%
TTM-10.29%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM63.88%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM63.59%

Return on Capital

10 Years18.85%
5 Years13.98%
3 Years13.64%
Last Year17.07%

NGVT Recent Earnings

Ingevity Corporation (NGVT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$1.15+36.9%
$0.84
Rev
$258M+1.3%
$255M
Q1 2026
Feb 25, 2026
Metric
Actual
Est
EPS
$0.58-12.8%
$0.67
Rev
$255M-0.8%
$257M
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$1.31+92.6%
$0.68
Rev
$333M+29.5%
$257M
Q3 2025
Aug 4, 2025
Metric
Actual
Est
EPS
$1.39+36.3%
$1.02
Rev
$365M-1.9%
$372M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$1.15vs $0.84+36.9%
$258Mvs $255M+1.3%
Q1 2026Feb 25, 2026
$0.58vs $0.67-12.8%
$255Mvs $257M-0.8%
Q4 2025Nov 5, 2025
$1.31vs $0.68+92.6%
$333Mvs $257M+29.5%
Q3 2025Aug 4, 2025
$1.39vs $1.02+36.3%
$365Mvs $372M-1.9%
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for Ingevity Corporation (NGVT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NGVT logoNGVTIngevity CorporationCurrent
$77.12$2.72B-16.73-16.98%-14.31%-148.6%—
FUL logoFULH.B. Fuller Company
$63.25$3.45B23.00-2.67%5.29%9.16%—
IOSP logoIOSPInnospec Inc.
$82.63$2.04B17.69-3.65%6.38%8.64%—
KWR logoKWRQuaker Chemical Corporation
$160.63$2.78B-1147.362.66%0.22%0.31%—
CBT logoCBTCabot Corporation
$93.40$4.88B15.52-7.04%7.97%16.75%—
ASIX logoASIXAdvanSix Inc.
$20.27$546.46M11.260.31%0.67%1.28%—

Compare NGVT vs Peers

Ingevity Corporation (NGVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FUL

Most directly comparable listed peer for NGVT.

Scale Benchmark

vs ECL

Larger-name benchmark to compare NGVT against a more recognizable public peer.

Peer Set

Compare Top 5

vs FUL, IOSP, KWR, CBT

NGVT SEC Filings & Documents

Ingevity Corporation (NGVT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Apr 15, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 5, 2025·SEC

Get notified when NGVT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NGVT Frequently Asked Questions

Ingevity Corporation (NGVT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Ingevity Corporation's revenue?

Ingevity Corporation (NGVT) reported $1.21B in revenue for fiscal year 2025. This represents a 24% increase from $980.0M in 2013.

How fast is Ingevity Corporation growing?

Ingevity Corporation (NGVT) saw revenue decline by 17.0% over the past year.

Is NGVT profitable?

Ingevity Corporation (NGVT) reported a net loss of $127.8M for fiscal year 2025.

Dividend & Returns
What is NGVT's return on equity?

Ingevity Corporation (NGVT) has a return on equity (ROE) of -148.6%. Negative ROE indicates the company is unprofitable.

What is Ingevity Corporation's free cash flow?

Ingevity Corporation (NGVT) generated $245.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in NGVT back in 2013?

Total return calculator · dividends reinvested · 13+ years of data

See returns →